Pregnancy Complications Affecting Fetus (Diagnosis) Clinical Trial
Official title:
Maternal Serum Pentraxin 3 in Early Pregnancy to Predict Gestational Diabetes Mellitus
NCT number | NCT03563638 |
Other study ID # | Quxiaoxian |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | October 1, 2015 |
Est. completion date | December 1, 2015 |
Verified date | June 2018 |
Source | Shanghai First Maternity and Infant Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
To investigate the association of maternal serum concentrations of pentraxin 3 in early pregnancy with gestational diabetes mellitus and to explore its potential value in the prediction of GDM.
Status | Completed |
Enrollment | 824 |
Est. completion date | December 1, 2015 |
Est. primary completion date | December 1, 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 27 Years to 33 Years |
Eligibility |
Inclusion Criteria: - Women with maternal age = 18 years, singleton pregnancy, primipara, no smoking, confirmed gestation=20 weeks and spontaneous conception were invited to participate in the study. Exclusion Criteria: - Women were excluded if they had multiple pregnancy, pre-gestational diabetes mellitus (PGDM), hypertensive disorders, preterm delivery, cardiovascular disease, immunological disease, glucocorticoid therapy, or other severe illness. In addition, women who were suffering from fetal abnormalities including chromosomally abnormal fetuses and/or structural defects and fetal growth restriction occurred during pregnancy were also excluded from the study. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Shanghai First Maternity and Infant Hospital |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Serum PTX3 levels in early pregnancy | Serum PTX3 levels in early pregnancy | 2015.10.01-2015.11.31 |